Semler Scientific (NASDAQ:SMLR) Given New $71.00 Price Target at Lake Street Capital

Semler Scientific (NASDAQ:SMLR) had its price target hoisted by Lake Street Capital from $40.00 to $71.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock.

Semler Scientific Price Performance

SMLR opened at $55.46 on Friday. The company has a 50 day simple moving average of $60.44 and a two-hundred day simple moving average of $40.30. The firm has a market cap of $514.11 million, a P/E ratio of 27.05 and a beta of 1.18. Semler Scientific has a 1-year low of $20.88 and a 1-year high of $81.56.

Semler Scientific (NASDAQ:SMLR) last released its earnings results on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The company had revenue of $13.51 million for the quarter.

Institutional Trading of Semler Scientific

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Newbridge Financial Services Group Inc. bought a new position in Semler Scientific in the 2nd quarter worth approximately $34,000. Quest Partners LLC boosted its position in shares of Semler Scientific by 48.0% during the third quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock worth $59,000 after acquiring an additional 817 shares during the last quarter. US Bancorp DE boosted its position in shares of Semler Scientific by 60.8% during the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock worth $72,000 after acquiring an additional 1,158 shares during the last quarter. Sanctuary Advisors LLC purchased a new position in Semler Scientific during the third quarter valued at $104,000. Finally, Rhumbline Advisers increased its holdings in Semler Scientific by 27.1% in the 2nd quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock valued at $213,000 after acquiring an additional 1,320 shares during the last quarter. Institutional investors own 49.37% of the company’s stock.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.